Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats

British Journal of Pharmacology

Volumn 156, Issue 1, 2009, Pages 94-104

  Ho, W S Vanessa ^a   Gardiner, Sheila M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anandamide; Cannabinoid receptors; Conscious rats; Fatty acid amide hydrolase; Haemodynamic responses; Hypertension; WIN55212 2

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; ANGIOTENSIN II; ARGIPRESSIN; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; BENZAMIDE DERIVATIVE; BENZOXAZINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; FATTY-ACID AMIDE HYDROLASE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; HEART RATE; HEMODYNAMICS; HYPERTENSION; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; STATISTICAL ANALYSIS; VASODILATATION; ACUTE DISEASE; ANIMAL; BLOOD PRESSURE; CONSCIOUSNESS; DRUG ANTAGONISM; DRUG EFFECT; HINDLIMB; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; SPLANCHNIC BLOOD FLOW; VASCULAR RESISTANCE; VASCULARIZATION; WISTAR RAT;

ACUTE DISEASE; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; BENZOXAZINES; BLOOD PRESSURE; CANNABINOIDS; CARBAMATES; CONSCIOUSNESS; HINDLIMB; HYPERTENSION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE; VASODILATION;

EID: 65549099178     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00034.x     Document Type: Article

References (47)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 209.
2. Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J et al. (2001). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7 : 827 832.
3. Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J et al. (2004). Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110 : 1996 2002.
4. Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60 : 155 163.
5. Carruba MO, Bondiolotti G, Picotti GB, Catteruccia N, Da Prada M (1987). Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol 134 : 15 24.
6. Cowley AW, Jr., Merrill D, Osborn J, Barber BJ (1984). Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res 54 : 163 172.
7. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 : 83 87.
8. Dendorfer A, Thornagel A, Raasch W, Grisk O, Tempel K, Dominiak P (2002). Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 40 : 348 354.
9. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK et al. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100 : 1538 1546.
10. Ellis EF, Moore SF, Willoughby KA (1995). Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol 269 : H1859 H1864.
11. Gardiner SM, March JE, Kemp PA, Bennett T (2001). Regional haemodynamic responses to the cannabinoid agonist, win 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br J Pharmacol 133 : 445 453.
12. Gardiner SM, March JE, Kemp PA, Bennett T (2002a). Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135 : 1889 1896.
13. Gardiner SM, March JE, Kemp PA, Bennett T (2002b). Influence of the CB(1) receptor antagonist, am 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. Br J Pharmacol 136 : 581 587.
14. Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME (1998). Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-o-(3-[35s]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 285 : 553 560.
15. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7 : 335 346.
16. Ho WS, Hillard CJ (2005). Modulators of endocannabinoid enzymic hydrolysis and membrane transport. Handb Exp Pharmacol 168 : 187 207.
17. Ho WS, Randall MD (2007). Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150 : 641 651.
18. Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118 : 2023 2028.
19. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR et al. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96 : 14136 14141.
20. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9 : 76 81.
21. Kwolek G, Zakrzeska A, Schlicker E, Gothert M, Godlewski G, Malinowska B (2005). Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. Br J Pharmacol 145 : 567 575.
22. Lake KD, Compton DR, Varga K, Martin BR, Kunos G (1997a). Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1- like cannabinoid receptors. J Pharmacol Exp Ther 281 : 1030 1037.
23. Lake KD, Martin BR, Kunos G, Varga K (1997b). Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29 : 1204 1210.
24. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D et al. (1999). Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42 : 769 776.
25. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 : 401 404.
26. Li J, Kaminski NE, Wang DH (2003). Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension 41 : 757 762.
27. Malinowska B, Kwolek G, Gothert M (2001a). Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 364 : 562 569.
28. Malinowska B, Piszcz J, Koneczny B, Hryniewicz A, Schlicker E (2001b). Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid op4 and cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol 364 : 233 241.
29. Mendizabal VE, Orliac ML, Adler-Graschinsky E (2001). Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. Eur J Pharmacol 427 : 251 262.
30. Movahed P, Evilevitch V, Andersson TL, Jonsson BA, Wollmer P, Zygmunt PM et al. (2005). Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Br J Pharmacol 146 : 171 179.
31. Niederhoffer N, Szabo B (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126 : 457 466.
32. Niederhoffer N, Szabo B (2000). Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J Pharmacol Exp Ther 294 : 707 713.
33. O'Sullivan SE, Kendall DA, Randall MD (2005). Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and n-arachidonoyldopamine (NADA) in the rat i/ated aorta. Eur J Pharmacol 507 : 211 221.
34. Pacher P, Batkai S, Kunos G (2004). Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. J Physiol 558 : 647 657.
35. Pacher P, Batkai S, Kunos G (2005a). Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology 48 : 1130 1138.
36. Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Liu J, Harvey-White J et al. (2005b). Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol 289 : H533 H541.
37. Randall MD, Kendall DA, O'Sullivan S (2004). The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142 : 20 26.
38. Theodorsson-Norheim E (1987). Friedman and quade tests: basic computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med 17 : 85 99.
39. Varga K, Lake K, Martin BR, Kunos G (1995). Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278 : 279 283.
40. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G (1996). Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28 : 682 686.
41. Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G (1997). Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390 : 518 521.
42. Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK et al. (2001). Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 38 : 2048 2054.
43. Wang Y, Kaminski NE, Wang DH (2005). VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension 46 : 986 991.
44. Wheal AJ, Bennett T, Randall MD, Gardiner SM (2007a). Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. Br J Pharmacol 152 : 717 724.
45. Wheal AJ, Bennett T, Randall MD, Gardiner SM (2007b). Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. Br J Pharmacol 150 : 662 671.
46. Xu L, Sved AF (2002). Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats. Am J Physiol Regul Integr Comp Physiol 283 : R451 R459.
47. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 : 452 457.